NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 48 filers reported holding NEUROCRINE BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $4,938,000 | -1.0% | 3,600,000 | 0.0% | 0.12% | -8.7% |
| Q4 2020 | $4,986,000 | -21.3% | 3,600,000 | -21.7% | 0.13% | -32.4% |
| Q3 2020 | $6,339,000 | -19.8% | 4,600,000 | -3.2% | 0.19% | -25.1% |
| Q2 2020 | $7,901,000 | +42.1% | 4,750,000 | +9.2% | 0.25% | +27.4% |
| Q1 2020 | $5,560,000 | +54.2% | 4,350,000 | +85.1% | 0.20% | +93.1% |
| Q4 2019 | $3,605,000 | +25.0% | 2,350,000 | +11.9% | 0.10% | +15.9% |
| Q3 2019 | $2,884,000 | +36.6% | 2,100,000 | +31.2% | 0.09% | +35.4% |
| Q2 2019 | $2,112,000 | -2.5% | 1,600,000 | 0.0% | 0.06% | -7.1% |
| Q1 2019 | $2,166,000 | +65.0% | 1,600,000 | +45.5% | 0.07% | +45.8% |
| Q4 2018 | $1,313,000 | -30.1% | 1,100,000 | 0.0% | 0.05% | -7.7% |
| Q3 2018 | $1,879,000 | +17.8% | 1,100,000 | 0.0% | 0.05% | +13.0% |
| Q2 2018 | $1,595,000 | – | 1,100,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| III Capital Management | 12,500,000 | $17,262,000 | 3.12% |
| CSS LLC/IL | 24,395,000 | $33,616,000 | 1.59% |
| Mint Tower Capital Management B.V. | 9,000,000 | $12,407,000 | 1.46% |
| Context Partners Fund, L.P. | 3,000,000 | $4,125,000 | 0.90% |
| Context Capital Management, LLC | 3,000,000 | $4,125,000 | 0.90% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,258,000 | $5,971,000 | 0.71% |
| SSI INVESTMENT MANAGEMENT LLC | 5,888,000 | $8,100,000 | 0.70% |
| Aequim Alternative Investments LP | 3,000,000 | $4,155,000 | 0.55% |
| WOLVERINE ASSET MANAGEMENT LLC | 32,181,000 | $44,437,000 | 0.40% |
| TWO SIGMA SECURITIES, LLC | 13,000,000 | $17,875,000 | 0.36% |